Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational, comparative effectiveness study

Emery, P; Gottenberg, J E; Rubbert-Roth, A; Sarzi-Puttini, P; Choquette, D; Martínez Taboada, V M; Barile-Fabris, L; Moots, R J; Ostor, A; Andrianakos, A; Gemmen, E; Mpofu, C; Chung, C; Gylvin, L Hinsch; Finckh, Axel

doi:10.1136/annrheumdis-2013-203993

Scientific article

English

Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational, comparative effectiveness study

ContributorsEmery, P; Gottenberg, J E; Rubbert-Roth, A; Sarzi-Puttini, P; Choquette, D; Martínez Taboada, V M; Barile-Fabris, L; Moots, R J; Ostor, A; Andrianakos, A; Gemmen, E; Mpofu, C; Chung, C; Gylvin, L Hinsch; Finckh, Axel

Published inAnnals of the rheumatic diseases, vol. 74, no. 6, p. 979-984

Publication date2015

Abstract

To compare the effectiveness of rituximab versus an alternative tumour necrosis factor (TNF) inhibitor (TNFi) in patients with rheumatoid arthritis (RA) with an inadequate response to one previous TNFi.

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de médecine

Research groups

Inflammation articulaire (44)

Citation (ISO format)

EMERY, P et al. Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational, comparative effectiveness study. In: Annals of the rheumatic diseases, 2015, vol. 74, n° 6, p. 979–984. doi: 10.1136/annrheumdis-2013-203993

Article (Published version)

Identifiers

PID : unige:45944
DOI : 10.1136/annrheumdis-2013-203993
PMID : 24442884

Journal ISSN0003-4967

576views

372downloads

Creation27/01/2015 15:40:00

First validation27/01/2015 15:40:00

Update24/01/2025 14:34:03

Status update24/01/2025 14:34:03

Last indexation24/01/2025 14:42:04

Archive ouverte UNIGE

Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational, comparative effectiveness study

To compare the effectiveness of rituximab versus an alternative tumour necrosis factor (TNF) inhibitor (TNFi) in patients with rheumatoid arthritis (RA) with an inadequate response to one previous TNFi.

Technical informations